Monitoring EBV DNA levels by quantitative PCR in patients at risk of EBV-associated lymphoproliferative disorders may allow timely recognition of virus reactivation and permit installment of antiviral treatment. Reportable Range is 200-2,000,000 copies/mL (2.30-6.30 Log Copies/mL).
If multiple CSF tests are being requested please specify order of importance
* This volume does not allow for repeat testing
Centrifuge and separate from cells within 24 hours of collection
Green Top Na Heparin Tube
GreenTop Li Heparin Tube
Frozen whole blood
Transport
Transport
EBV DNA, QN PCR: Not Detected (IU/mL)
EBV DNA, QN PCR: Not Detected (Log IU/mL)
Monitoring EBV DNA levels by quantitative PCR in patients at risk of EBV-associated lymphoproliferative disorders may allow timely recognition of virus reactivation and permit installment of antiviral treatment. Reportable Range is 200-2,000,000 copies/mL (2.30-6.30 Log Copies/mL).
1 to 2 days
0091779
87799